Literature DB >> 20827427

Carotid Intima-media thickness in childhood and adolescent obesity relations to abdominal obesity, high triglyceride level and insulin resistance.

Jie Fang1, Jian Ping Zhang, Cai Xia Luo, Xiao Mei Yu, Lan Qiu Lv.   

Abstract

AIM: To investigate risk factors which impact on common carotid artery intima media thickness (IMT).
METHODS: A total of 86 obese children and adolescents and 22 healthy children and adolescents with normal weight were enrolled. Moreover, 23 of 86 obese children and adolescents were diagnosed with metabolic syndrome (MetS). The clinical, biochemical data and the IMT of the common carotid artery were measured in all subjects.
RESULTS: Obese and obese with MetS subjects demonstrated a significantly (p < 0.01) thicker intima media (0.69mm, 0.66mm) as compared to the control group (0.38mm), but there was no significant difference of IMT between obese and MetS group. IMT was correlated to body weight, body mass index, waist circumference, waist to hip ratio, systolic blood pressure, diastolic blood pressure, fasting insulin, homoeostasis model assessment-insulin resistance, triglyceride, high-density lipoprotein- cholesterol, low-density lipoprotein-cholesterol, alanine aminotransferase, aspartate aminotransferase and fatty liver. Waist circumference, waist to hip ratio, triglyceride and homoeostasis model assessment-insulin resistance were independent determinants of mean IMT level.
CONCLUSION: Obesity especially abdominal obesity, high TG and insulin resistance may be the main risk predictors of increased IMT.

Entities:  

Keywords:  adolescents; children; intima-media thickness; metabolic syndrome; obesity

Mesh:

Substances:

Year:  2010        PMID: 20827427      PMCID: PMC2934726          DOI: 10.7150/ijms.7.278

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


Introduction

The rapidly increasing prevalence of obesity among children is one of the most challenging problems. The prevalence of the metabolic syndrome (MetS) in children is increasing exponentially because of global increase in obesity. As indicated in previous studies 1,2,3, children and adolescents with risk factors such as obesity, dyslipidemia, elevated blood pressure and impaired glucose metabolism are at increased risk of developing atherosclerosis in adulthood. It has been found that obesity results in the early onset of adulthood chronic disease such as cardio-cerebrovascular disease. Recent researches 4,5,6 have revealed that adiposity-associated inflammatory factors such as C-reactive protein (CRP), interleukin (IL)-6 and tumor necrosis factor (TNF)-α may play a role in promoting adverse vascular outcomes. The intima media thickness (IMT) of the common carotid artery (CCA) is a well-known marker of subclinical atherosclerosis and is a noninvasive, feasible, reliable and inexpensive method for detecting development of subclinical atherosclerosis. Studies in adults have revealed that IMT was related to cardiovascular risk factors and could predict the possibility of future cardio-cerebrovascular disease 7,8. Increase IMT was also reported in children with obesity, familial hypercholesterolemia and nonalcoholic fatty liver disease (NAFLD) compared with control children. There has been no statistical data about the association between IMT and the components of MetS since new definition for children and adolescent MetS was published by International Diabetes Federation (IDF). This study aimed to verify the relationships among obesity, dyslipidemia, elevated blood pressure, impaired glucose metabolism, chronic inflammation, fatty liver and IMT to explore as to which of these factors are related to IMT.

Subjects and Methods

Subjects

A total of 86 obese Chinese children were enrolled from July 2008 to March 2009. The obese group was defined as obese children without MetS, which included 46 boys and 17 girls with a mean age of 10.5 ± 1.6 years (range 7.4 to 13.3 years). The MetS group was defined as obese children with MetS, which included 18 boys and 5 girls with a mean age of 10.9 ± 1.6 years (range 7.6 to 14.2 years). Children with other chronic disease (endocrine disease, hereditary disease, or systemic inflammation) or those taking any medications were excluded. The control group consisted of 22 healthy non-obese children, which included 16 boys and 6 girls with a mean age of 11.1 ± 2.1 years (ranging from 7.6 to 14.8 years). Consent was obtained from the parents and the Ethical Committee of the Children's Hospital of Zhejiang University School of Medicine.

Diagnostic Criteria

Obesity was defined as body mass index (BMI) ≥95th percentile using the childhood date of Working Group on Obesity in China (WGOC) 9. According to the IDF criteria for children and adolescents 10, MetS was identified if a subject had increased waist circumference ( > 90th percentile) 11 and also had ≥ 2 of the following: 1) impaired fasting blood glucose ( ≥ 5.6 mmol/L ), or Type 2 Diabetes Mellitus; 2) increased blood pressure ( ≥ 130 mmHg systolic and/or ≥ 85 mmHg diastolic ); 3) elevated plasma triglycerides ( ≥ 1.7 mmol/L ); 4) high plasma high-density lipoprotein cholesterol ( < 1.03 mmol/L).

Clinical characteristics

The body weight was assessed using a calibrated standard balance beam, height was measured by a standard height bar, and BMI was calculated as body weight (kg) divided by square height (m2). Waist circumference (WC) was measured at the midway between the lower rib and the iliac crest, hip circumference was measured at the widest part at the gluteal region. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured twice at the right arm after a 10-minute rest in the supine position using an automated sphygmomanometer.

Biochemical measurements

Samples were drawn between 8 and 9 am after fasting for 10 hours. Triglycerides (TG), total cholesterol (TC) were measured by enzymatic and cholesterol oxidase method respectively, high plasma high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were both detected by the direct assay method, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were tested by enzyme-linked immunosorbent assay method. Fasting plasma glucose (FPG) was measured by glucose oxidase method; fasting plasma insulin (FINS) was measured by radioimmunity assay (Modula Analytics PP, Roche). Both intra-assay and inter-assay coefficient of variations were less than 2.1% and 4.4%, respectively. Plasma levels of IL-6 and TNF were measured by enzyme-linked immunosorbent assay method (Ju Ying bioscitech, Shenzhen, China), with both intra-assay and inter-assay coefficient of variations being less than 10%.

IMT measurement

IMT was measured by B-mode ultrasound using a 10-MHz linear transducer (Philips HD7). The subjects were examined supine with the neck extended and the probe in the antero-lateral position. All measurements of IMT were made in the longitudinal plane at the point of maximum thickness on the far wall of the common carotid artery along a 1 cm section of the artery proximal to the carotid bulb. The IMT was defined as the distance between the intimia-blood interface and the adventitia-media junction. After freezing the image, the measurements were made using electronic calipers. The maximal thicknesses of the intima-media width were measured to give three readings and the mean value was used for statistical purposes.

Statistical analysis

Statistical analysis was performed with SPSS 13.0. WHR, FBG, HOMA-IR, TNF were normalized by log-transformation. Statistically significant differences were tested for qualitative items by χ2 test and for quantitative items by One-Way ANOVA. Thereafter, associations were examined by Pearson correlation analysis for continuous variables, and by Spearman correlation analysis for categorical variables. Finally, multiple stepwise linear regression analysis was used to examine relationships between mean IMT and all other variables investigated. A p<0.05 was considered statistically significant.

Results

The characteristics of three groups

The obese and MetS group both demonstrated increased mean IMT, body weight, BMI, WC, WHR, SBP, FINS, HOMA-IR, lg (HOMA-IR), TG, LDL-C, ALT and AST levels, decreased HDL-C levels and higher prevalence of fatty liver (p < 0.05). Furthermore, the MetS group showed higher DBP compared with the control group. The children of MetS group had higher values of WC, SBP and TG, and lower HDL-C than these of obese group. There was no statistical difference in the age and sex among three groups (p = 0.400, 0.672), as shown in table 1.
Table 1

The characteristics of obese, MetS and control groups

MetS groupObese groupControl groupF/χ2P
Age(y)10.9 ± 1.610.5 ± 1.611.1 ± 2.10.9240.400
Sex(F/M)18/546/1716/60.4250.672
Weight(kg)70.15**60.65**31.8696.045<0.001
BMI(kg/m2)29.63**28.04**17.32182.510<0.001
WC(cm)94.22**#88.83**58.8394.835<0.001
WHR0.96**0.96**0.7646.027<0.001
lg(WHR)-0.02**-0.02**-0.1240.424<0.001
SBP(mmHg)122.3**#111.67**103.3215.079<0.001
DBP(mmHg)70.91**67.0663.146.9940.002
FBG(mmol/L)5.575.035.271.3790.267
lg (FBG)0.730.700.7232.3600.289
FINS(mmol/L)29.36**18.05**5.6232.237<0.001
HOMA-IR7.36**4.20**1.3425.565<0.001
lg (HOMA-IR)0.72** #0.50**0.0424.075<0.001
TG(mmol/L)2.53** ##1.44**0.9527.587<0.001
TC(mmol/L)4.404.423.8827.5870.127
HDL-C(mmol/L)0.94** ##1.29**1.5437.089<0.001
LDL-C(mmol/L)2.94**2.72**2.059.566<0.001
Fatty liver(%)78.26**58.73**0.0031.242<0.001
ALT(mmol/L)64.87**61.17**14.9545.136<0.001
AST(mmol/L)39.83**41.03**24.4150.9530.001
IL-6(pg/ml)5.064.324.261.9820.143
TNF(pg/ml)26.3026.0323.550.0710.931
lg (TNF)1.341.291.350.5480.580
mean IMT(mm)0.69**0.66**0.3867.970<0.001

BMI = body mass index; WC = waist circumference; WHR = waist to hip ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; FBG = fasting blood glucose; FINS = fasting insulin; HOMA-IR = homoeostasis model assessment- insulin resistance; TG = triglyceride; TC = total cholesterol; HDL-C = high-density lipoprotein- cholesterol; LDL-C = low-density lipoprotein-cholesterol; ALT = alanine aminotransferase; AST = aspartate aminotransferase; lg = logarithmical transformation; Compared to control group, **P<0.01, *P<0.05; Compared to obese group, ##P<0.01, #P<0.05.

The relationship between IMT and all other variables investigated

In all subjects, mean IMT of CCA was significantly related to body weight, BMI, WC, lg (WHR), SBP, DBP, FINS, lg (HOMA-IR), TG, HDL-C, LDL-C, ALT, AST and fatty liver, as shown in table 2. IMT was not significantly related to age, sex, FBG, TC, IL-6 and lg (TNF).
Table 2

Correlation between mean IMT and all other variables

VariableMean IMT
rp
Age(y)0.090.364
Sex0.010.935
Weight(kg)0.63<0.001
BMI(kg/m2)0.68<0.001
WC(cm)0.70<0.001
lg (WHR)0.64<0.001
SBP(mmHg)0.270.006
DBP(mmHg)0.210.033
lg(FBG)-0.010.944
FINS(mmol/L)0.39<0.001
lg (HOMA-IR)0.58<0.001
TG(mmol/L)0.41<0.001
TC(mmol/L)0.170.080
HDL-C(mmol/L)-0.41<0.001
LDL-C(mmol/L)0.280.004
Fatty liver0.35<0.001
ALT(mmol/L)0.35<0.001
AST(mmol/L)0.300.002
IL-6(pg/ml)0.170.082
lg (TNF)0.030.780

BMI = body mass index; WC = waist circumference; WHR = waist to hip ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; FBG = fasting blood glucose; FINS = fasting insulin; HOMA-IR = homoeostasis model assessment- insulin resistance; TG = triglyceride; TC = total cholesterol; HDL-C = high-density lipoprotein- cholesterol; LDL-C = low-density lipoprotein-cholesterol; ALT = alanine aminotransferase; AST = aspartate aminotransferase; lg = logarithmical transformation.

Finally, the multiple stepwise linear regression analysis showed that WC, lg (WHR), TG, lg (HOMA-IR) were independent determinants of mean IMT level. All the other factors were excluded in the equations, as shown in table 3.
Table 3

Multiple stepwise linear regression analysis, with mean IMT of CCA as the dependent variable and all other variables investigated as the independent variable in all subjects

Regression CoefficientStandardized Coefficient95% Confidence intervalP
WC(cm)0.0030.2920.001∼0.0050.009
lg(WHR)0.6660.2210.077∼1.2550.027
TG(mmol/L)0.0380.2220.014∼0.0620.002
lg(HOMA-IR)0.2570.6620.149∼0.366<0.001

WC = waist circumference; WHR = waist to hip ratio; TG = triglyceride; HOMA-IR = homoeostasis model assessment- insulin resistance; lg = logarithmical transformation.

Discussion

IMT is a well-known marker of subclinical atheroscerosis and it also can indicate future cardio-cerebrovascular disease 8,12,13. Recent reports indicate that the presence of obesity in childhood is associated with increased adult IMT 2,3. In our study we measured the IMT in obese and nonobese subjects. We found that IMT in obese children and adolescents was significantly increased as compared with non obese children of similar age and sex, which was in accordance with other studies 14,15,16. This tendency was further intensified in the presence of MetS. IMT was closely associated with obesity especially abdominal obesity in childhood and adolescence as confirmed by our correlation analysis and regression analysis. Obesity has been demonstrated to be associated with cardiovascular risk factors, such as hypertension, dyslipidemia, impaired glucose metabolism and chronic inflammation not only in adults but also in children and adolescents. In our study, IMT was significantly related to lg (HOMA-IR) and TG in both bivariate correlation and multiple stepwise linear regression analysis, suggesting a link between IMT, insulin resistance and dyslipidemia. Insulin resistance is a common phenomenon and plays an important role in the cardio-cerebrovascular disease in obese population 17,18. In our study, the obese and MetS group both demonstrated increased fasting insulin than control group rather than fasting blood glucose. Meanwhile, fasting insulin and HOMA-IR levels were significantly related to IMT, however, fasting blood glucose was not related. This information demonstrates that an increased insulin levels seem to be an earlier predictor for atherogenic changes than hyperglycemia, and concur with data published by Atabek et al 19. Insulin not only directly stimulates the expression of vascular cell adhesion molecule 20, but disrupts the balance between the production of NO and ET-1 leading to endothelial dysfunction 21. Our regression analysis showed that lg (HOMA-IR) was an independent determinant of mean IMT level, which indicates that insulin resistance was involved in the basic pathological changes associated of obesity 22, and was closely related to cardio-cerebrovascular disease. Dyslipidemia, especially low HDL-C and high LDL-C, or a high TG is related to cardio-cerebrovascular disease 23,24. These risk factors association with IMT was also shown in our study. According to Pearson correlation analysis, HDL-C, LDL-C and TG were all related to IMT. Therefore, dyslipidemia and cardio-cerebrovascular disease were inseparable. In addition, prevalence of nonalcoholic fatty liver in obese subjects with and without MetS was 78.26%, 58.73% respectively. In contrast, non obese children and adolescents had no fatty liver disease. The correlation between the fatty liver and IMT was significant. It was shown that nonalcoholic fatty liver disease (NAFLD) patients had an increase IMT compared with control subjects in children, just as many other studies have reported 25,26,27. Deficiencies still exist in our study. First, our sample size was not large enough, especially the number of MetS group. The levels of SBP, DBP, IL-6 and TNF were not statistically related to IMT as other research 4,5,28,29,30. However, the trend of increase was noted. This bias might due to the small sample size. Second, we used the standard of WC in Beijing rather than Zhe Jiang province, which might influence samples selection. Finally, the IMT may also probably be influenced by other risk factors which have not been tested in our study. In conclusion, atherosclerosis begins in obese children and adolescents, and this tendency is intensified in the presence of MetS. Obesity especially abdominal obesity, high TG level and insulin resistance are strong predictors of increased IMT.
  27 in total

1.  Increased carotid intima-media thickness and stiffness in obese children.

Authors:  Arcangelo Iannuzzi; Maria Rosaria Licenziati; Ciro Acampora; Vittorio Salvatore; Lucia Auriemma; Maria Luigia Romano; Salvatore Panico; Paolo Rubba; Maurizio Trevisan
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

2.  Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.

Authors:  A Zanchetti; G Crepaldi; M G Bond; G V Gallus; F Veglia; A Ventura; G Mancia; G Baggio; L Sampieri; P Rubba; S Collatina; E Serrotti
Journal:  J Hypertens       Date:  2001-01       Impact factor: 4.844

3.  Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study.

Authors:  P H Davis; J D Dawson; W A Riley; R M Lauer
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

Review 4.  [Carotid intima-media thickness measured by ultrasonography: effect of different pharmacotherapies on atherosclerosis progression].

Authors:  László Csiba
Journal:  Orv Hetil       Date:  2005-06-05       Impact factor: 0.540

5.  Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

Authors:  Nicola Villanova; Simona Moscatiello; Stefano Ramilli; Elisabetta Bugianesi; Donatella Magalotti; Ester Vanni; Marco Zoli; Giulio Marchesini
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

6.  [Obesity and insulin resistance among adolescents from Chiapas].

Authors:  R M Velasco-Martínez; A Jiménez-Cruz; F Higuera Domínguez; E Domínguez de la Piedra; M Bacardí-Gascón
Journal:  Nutr Hosp       Date:  2009 Mar-Apr       Impact factor: 1.057

7.  Arterial intima-media thickening and endothelial dysfunction in obese Chinese children.

Authors:  Weihua Zhu; Xianmei Huang; Jin He; Mengxia Li; Henning Neubauer
Journal:  Eur J Pediatr       Date:  2005-03-05       Impact factor: 3.183

8.  Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study.

Authors:  Olli T Raitakari; Markus Juonala; Mika Kähönen; Leena Taittonen; Tomi Laitinen; Noora Mäki-Torkko; Mikko J Järvisalo; Matti Uhari; Eero Jokinen; Tapani Rönnemaa; Hans K Akerblom; Jorma S A Viikari
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

9.  Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study.

Authors:  Shengxu Li; Wei Chen; Sathanur R Srinivasan; M Gene Bond; Rong Tang; Elaine M Urbina; Gerald S Berenson
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

10.  Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study).

Authors:  Elaine M Urbina; Sathanur R Srinivasan; Rong Tang; M Gene Bond; Lyn Kieltyka; Gerald S Berenson
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778

View more
  23 in total

1.  Increased intima media thickness at many arterial sites in obese adolescents with abdominal adiposity, insulin resistance, and high LDL-cholesterol.

Authors:  M Wasniewska; M Valenzise; A Manganaro; S Bombaci; R Iudicello; T Aversa; F De Luca; F Lombardo
Journal:  J Endocrinol Invest       Date:  2011-09       Impact factor: 4.256

2.  Physical activity and cardiorespiratory fitness, but not sedentary behavior, are associated with carotid intima-media thickness in obese adolescents.

Authors:  António Ascenso; António Palmeira; Luís Mendes Pedro; Sandra Martins; Helena Fonseca
Journal:  Eur J Pediatr       Date:  2015-10-21       Impact factor: 3.183

3.  Early atherogenesis and visceral fat in obese adolescents.

Authors:  A H Slyper; H Rosenberg; A Kabra; M J Weiss; B Blech; S Gensler; M Matsumura
Journal:  Int J Obes (Lond)       Date:  2014-01-23       Impact factor: 5.095

4.  Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand.

Authors:  Prakul Chanthong; Keswadee Lapphra; Supawan Saihongthong; Sirintip Sricharoenchai; Orasri Wittawatmongkol; Wanatpreeya Phongsamart; Supattra Rungmaitree; Nantaka Kongstan; Kulkanya Chokephaibulkit
Journal:  AIDS       Date:  2014-09-10       Impact factor: 4.177

5.  Correlative association of interleukin-6 with intima media thickness: a meta-analysis.

Authors:  Bo Zhang; Jing Wang; Yong Xu; Xiao Zhou; Junsong Liu; Jing Xu; Bo Li; Guang Zhi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Adiposity has no direct effect on carotid intima-media thickness in adolescents and young adults: Use of structural equation modeling to elucidate indirect & direct pathways.

Authors:  Zhiqian Gao; Philip R Khoury; Connie E McCoy; Amy S Shah; Thomas R Kimball; Lawrence M Dolan; Elaine M Urbina
Journal:  Atherosclerosis       Date:  2015-12-08       Impact factor: 5.162

7.  Body composition phenotypes and carotid intima-media thickness in 11-13-year-old children.

Authors:  Xavier Melo; Helena Santa-Clara; Nuno M Pimenta; Margarida Carrolo; Sandra S Martins; Cláudia S Minderico; Bo Fernhall; Luís B Sardinha
Journal:  Eur J Pediatr       Date:  2013-10-06       Impact factor: 3.183

Review 8.  Cardiovascular disease in childhood: the role of obesity.

Authors:  Despina Herouvi; Evangelos Karanasios; Christina Karayianni; Kyriaki Karavanaki
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

9.  Prevalence of Acanthosis nigricans and Related Factors in Iranian Obese Children.

Authors:  Fatemeh Sayarifard; Azadeh Sayarifard; Bahar Allahverdi; Sara Ipakchi; Mastaneh Moghtaderi; Bahareh Yaghmaei
Journal:  J Clin Diagn Res       Date:  2017-07-01

10.  HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.

Authors:  Preethi Mani; Kiyoko Uno; MyNgan Duong; Kathy Wolski; Steven Spalding; M Elaine Husni; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.